Abstract
Handling and managing uncertainty provide an additional communication challenge for patients with cancer and their physicians. Addressing and treating not only physical symptoms but also distress, anxiety, and fear are vital to a good outcome. Doctors need to recognize the importance of providing structure and a safe relationship to facilitate coping and can do so through clear and supportive communication.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Christakis NA. Death foretold. Prophecy and prognosis in medical care. Chicago, IL: The University of Chicago Press; 1999.
Spiegel D. A 43 year-old woman coping with cancer. JAMA. 1999;28(4):371–8.
Weisman AD, Worden JW. The existential plight in cancer: significance of the first 100 days. Int J Psychiatry Med. 1976–1977;7(1):1–15.
Weisman AD, Worden JW. The emotional impact of cancer recurrence. J Psychosoc Oncol. 1985;3:5–16.
The AM, Hak T, Koeter G, et al. Collusion in doctor-patient communication about imminent death: an ethnographic study. BMJ. 2000;321:1376-81.
Earle CC, Landrum MB, Souza JM, et al. Aggressiveness of cancer care near the end of life: is it a quality of care issue? J Clin Oncol. 2008;26(23):3860–6.
Block SD. Perspectives on care at the close of life. Psychological considerations, growth, and transcendence at the end of life: the art of the possible. JAMA. 2001;285(22):2898–905.
Gadgeel SM. Hope and realism: the perfect balance? J Clin Oncol. 2011;29(16):2291–2
Fallowfield L. Truth sometimes hurts but deceit hurts more. In: Surbone A, Zwitter M, editors. Communication with the cancer patient, vol. 809. New York: The New York Academy of Sciences; 1997. p. 525–36.
Chapman K, Abraham C, Jenkins V, et al. Lay understanding of terms used in cancer consultations. Psychooncology. 2003;12:557–66.
Brown RF, Hill C, Burant CJ. Satisfaction of early breast cancer patients with discussions during initial consultations with a medical oncologist. Psychooncology. 2009;18(1):42–9.
Pollak KI, Arnold RM, Jeffreys AS. Oncologist communication about emotion during visits with patients with advanced cancer. J Clin Oncol. 2007;25:5748–52.
Kennifer SL, Alexander SC, Pollak KI, et al. Negative emotions in cancer care: do oncologists’ responses depend on severity and type of emotion. Patient Educ Couns. 2009;76(1):51–6.
Levinson W, Gorawara-Bhat R, Lamb J. A study of patient clues and physician response in primary care and surgical settings. JAMA. 2000;284:1021–7.
Riess H. Empathy in medicine—a neurobiological perspective. JAMA. 2010;304(14):1604–5.
Schapira L, Butow P, Brown R. Pessimism is no poison. J Clin Oncol. 2010;28(4):705–7.
Schapira L. Shared uncertainty. J Support Oncol. 2004;2(1):14–8.
Institute of Medicine. Cancer care for the whole patient: meeting psychosocial health needs. Bethesda: The National Academies Press; 2007 http://www.iom.edu.
Kravitz RL, Tancredi DJ, Grennan T, et al. Cancer health empowerment for living without pain (Ca-HELP): effects of a tailored education and coaching intervention on pain and impairment. Pain. 2011;152(7):1572–82.
Cella DF. Health promotion in oncology: a cancer wellness doctrine. J Health Care Chaplain. 1992;4:87–101.
Yellen SB, Cella DF. Someone to live for: social well-being, parenthood status, and decision-making in oncology. J Clin Oncol. 1995;13:1255–64.
Mishel MH, Germino BB, Lin L, et al. Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns. 2009;77(3):349–59.
Kleinman A. What really matters. Living a moral life amidst uncertainty and danger. Oxford: Oxford University Press; 2006.
Diamond J. Because cowards get cancer too: a hypochondriac confronts his nemesis. New York: Crown; 1999.
Hilbig B. Sad, thus true: negativity bias in judgements of truth. J Exp Soc Psychol. 2009;45(4):983–6.
Rodriguez KL, Gambino F, Butow P, et al. It’s going to shorten your life: framing of oncologist–patient communication about prognosis. Psychooncology. 2008;17(3):219–25.
Heaven CM, Maguire P. Disclosure of concerns by hospice patients and their identification by nurses. Palliat Med. 1997;11:283–90.
Parle M, Jones B, Maguire P. Maladaptive coping and affective disorders among cancer patients. Psychol Med. 1996;26:735–44.
Epstein RM, Street RL. Patient-centered communication in cancer care: promoting healing and reducing suffering. NIH Publication No 07-6225. Bethesda, MD: National Cancer Institute; 2007.
Fogarty LA, Curbow BA, Wingard JR, et al. Can 40 seconds of compassion reduce anxiety? J Clin Oncol. 1999;17:371–9.
Ford S, Fallowfield L, Lewis S. Can oncologists detect distress in their out-patients and how satisfied are they with their performance during bad news consultations? Br J Cancer. 1994;70:767–77.
Halpern J. From detached concern to empathy. Humanizing medical practice. New York: Oxford University Press; 2001.
Friedrichsen MJ, Strang PM. Doctors’ strategies when breaking bad news to terminally ill patients. J Palliat Med. 2003;6:565–74.
Witte K, Allen M. A meta-analysis of fear appeals: implications for effective public health campaigns. Health Educ Behav. 2000;27:591–615.
Weinfurt KP, Seils DM, Tzeng JP, et al. Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent. Med Decis Making. 2008;28:575–81.
Miller FG, Joffe S. Benefit in phase I oncology trials: therapeutic misconception or reasonable treatment option? Clin Trials. 2008;5(6):617–23.
Jenkins V, Solis-Trapala I, Langridge C, et al. What oncologists believe they said and what patients believe they heard: an analysis of phase I trial discussions. J Clin Oncol. 2011; 29(1):61–8.
Brown R, Bylund C, Siminoff LA, et al. Seeking informed consent to phase I cancer clinical trials: identifying oncologists’ communication strategies. Psychooncology. 2011;20(4):361–8.
Albrecht TL, Eggly S, Gleason ME. Influence on clinical communication on patients’ decision-making on participation in clinical trials. J Clin Oncol. 2008;26(16):2666–73.
Weinfurt KP. Varieties of uncertainty and the validity of informed consent. Clin Trials. 2008;5:624–5.
Kass NE. Early phase clinical trials: communicating the uncertainties of magnitude of benefit and likelihood of benefit. Clin Trials. 2008;5:627.
Disclosure
I have no disclosures regarding funding or sources of support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schapira, L. (2013). Managing Uncertainty. In: Surbone, A., Zwitter, M., Rajer, M., Stiefel, R. (eds) New Challenges in Communication with Cancer Patients. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-3369-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3369-9_3
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-3368-2
Online ISBN: 978-1-4614-3369-9
eBook Packages: MedicineMedicine (R0)